Introduction {#S1}
============

Being a broad-spectrum antibiotic with unique property of inhibiting the prokaryotic RNA polymerase activity ([@B39]; [@B3]), rifamycin and its derivatives (e.g., rifampicin, rifabutin, rifapentine, and rifaximin) are still broadly used as the first-line antimycobacterial agents ([@B28]). To increase rifamycin yield, multiple strategies have been tested, including both engineering the producer *Amycolatopsis mediterranei* (a rare actinomycete) ([@B25]; [@B14]) and optimizing fermentation conditions ([@B11]; [@B15]; [@B22]). Among those tested conditions, supplementation of nitrate was found to be able to remarkably stimulate rifamycin production, which has become known as the "nitrate-stimulating effect (NSE)" ([@B11]). This phenomenon was first reported by our laboratory about 40 years ago, and has been widely exploited in the industrial production of rifamycin SV.

With the assistance of stable isotope tracing technology, it was found that the nitrogen atom of nitrate can be incorporated into the rifamycin at last, and both intracellular nitrogen metabolites and the biosynthesis of rifamycin precursors are greatly promoted upon nitrate supplementation ([@B12]; [@B13]). Later, to better understand rifamycin biosynthesis, the rifamycin biosynthetic gene cluster (*rif* cluster) and the complete genome of *A. mediterranei* were sequenced ([@B1]; [@B48]). The *rif* cluster, consisting of 43 genes (i.e., from *rifS* to *rifZ*, [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}) ([@B7]; [@B17]), includes genes involved in the synthesis of the starter unit AHBA (3-amino-5-hydroxybenzoic acid), assembly and modification of the polyketide backbone, downstream processing and conversion of rifamycin, and resistance ([@B46]; [@B40], [@B41]; [@B8]; [@B9]; [@B47]). In addition, the genome annotation results of *A. mediterranei* U32 indicate that the *rif* cluster contains two canonical transcriptional regulators: the LuxR-family transcriptional regulator RifZ and the TetR-family transcriptional regulator RifQ ([@B48]). Recently, our studies have revealed that RifZ is a pathway-specific regulator of the *rif* cluster and directly activates the transcription of all *rif* cluster genes ([@B17]), and RifQ could reduce the intracellular toxicity of rifamycin via directly regulating the expression of the rifamycin exporter-encoding gene *rifP* ([@B16]).

About the molecular mechanism of NSE, our previously published results of the RNA-seq analysis in *A. mediterranei* U32 have provided more comprehensive insights: supplementation of nitrate is able to remarkably increase the transcripts of the *rif* cluster genes to accumulate more rifamycin-biosynthesis enzymes; furthermore, the transcriptions of some other genes (such as *glnA* and *nas* operon) are also profoundly activated by nitrate supplementation to furnish more precursors for rifamycin biosynthesis ([@B31]). Accordingly, in that work we speculate that nitrate could stimulate the rifamycin production via increasing both the precursor supply and the biosynthetic enzyme accumulation ([@B31]). In addition, our previous genetic analyses have established that GlnR may participate in the nitrate-mediated regulation on rifamycin biosynthesis, as the deletion of *glnR* from *A. mediterranei* resulted in the loss of NSE ([@B45]); however, the underlying molecular mechanism remains ill-defined.

In actinomycetes, GlnR is an OmpR-type transcriptional regulator, and those early studies show that most GlnR-regulated genes (e.g., *amtB*, *nirB*, *nasA*, *ureA*, *glnA*, and *ald*) are involved in the assimilation and utilization of a variety of nitrogen sources, such as ammonium, nitrate and urea ([@B6]; [@B33]; [@B35]; [@B36], [@B38], [@B37]). Accordingly, the GlnR in actinomycetes is mainly considered as a global nitrogen metabolism regulator. Later, increasing evidences demonstrate that GlnR also regulates the transcription of other genes involved in carbon metabolism, antibiotic biosynthesis and so on ([@B18]; [@B27]; [@B30]; [@B4]; [@B10]; [@B43]; [@B21]).

In this study, the *in vivo* analyses clearly reveal that GlnR positively regulates *rif* cluster transcription and rifamycin biosynthesis in *A. mediterranei* U32. Then the EMSAs and DNase I footprinting assays show that GlnR can specifically bind to the upstream regions of genes *rifK* and *rifZ*, respectively, which lead us to disclose that both genes in fact have their own promoters on the basis of primer extension assays. It is well-known that RifK is responsible for the rifamycin starter unit AHBA biosynthesis, and RifZ is the pathway-specific regulator for the whole *rif* cluster transcription. Therefore, one may easily conclude that GlnR both directly and indirectly regulates *rif* cluster genes transcription to control rifamycin biosynthesis, which well interprets our previous findings that the deletion of *glnR* resulted in the loss of NSE in *A. mediterranei*.

Results {#S2}
=======

GlnR Positively Regulates Rifamycin Biosynthesis Through Activating the Transcription of *rif* Cluster {#S2.SS1}
------------------------------------------------------------------------------------------------------

To explore the role of GlnR in the NSE in *A. mediterranei* U32, we carefully compared the time course of bacterial growth and rifamycin yield between the *glnR*^--^ and *glnR*^+^ strains. The *glnR* null mutant (Δ*glnR*) was constructed using double crossover recombination ([@B45]; [@B19]). To obtain the *glnR* complemented strain (*glnR*+), the *glnR* gene (with its native promoter) was integrated into the chromosome of Δ*glnR*, employing the integrative plasmid pDZL803 as the vector ([@B19]; [@B17]). As a control, Δ*glnR* was integrated with the vector to obtain Δ*glnR*/803 ([@B19]), which was used to investigate the influence of the empty plasmid on both bacterial growth and rifamycin production.

In liquid Bennet medium supplemented with 80 mM nitrate, the above four strains showed similar growth rates before 48 h ([Figure 1A](#F1){ref-type="fig"}). After 48 h, the wild type U32 and *glnR*+ strains started to produce a large amount of rifamycin, but Δ*glnR* and Δ*glnR*/803, both of which showed a higher growth rate, produced significantly less rifamycin (only ∼15% of the wild type) by 120 h ([Figure 1](#F1){ref-type="fig"}). Moreover, although the Δ*glnR* showed a little higher growth rate than the wild type U32 when grown in liquid Bennet medium without nitrate, it had a significantly lower yield of rifamycin than the yield of U32 ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}), which was similar with the above results under nitrate condition. Based on these results, one may conclude that GlnR has weakly negative effect on bacterial growth but positively regulates the rifamycin biosynthesis in *A. mediterranei*.

![Effects of the *glnR* deletion on bacterial growth and rifamycin production in *A. mediterranei* when cultured in liquid Bennet medium containing 80 mM KNO~3~. **(A)** Growth curves of four *A. mediterranei* strains were determined by measuring the OD~600~ values of the cultures. **(B)** The rifamycin yield was measured with the differential spectrophotometric method. Error bars represented the SD from three independent biological replicates. U32, the wild type; Δ*glnR*, the *glnR* null mutant; *glnR*+, Δ*glnR* complemented with an intact *glnR*; Δ*glnR*/803, *glnR* null mutant integrated with the vector pDZL803.](fmicb-11-00319-g001){#F1}

Then we used quantitative real-time PCR (qRT-PCR) to determine the potential regulatory influence of GlnR on the transcription of *rif* cluster. The same four strains were cultured in liquid Bennet medium supplemented with 80 mM nitrate, and samples were taken for RNA extraction at 24, 48, and 72 h, which respectively represented the early mid-logarithmic phase, mid-logarithmic phase, and early stationary phase (ref to the [Figure 1A](#F1){ref-type="fig"}). Our previous work has established that the *rif* cluster consists of 10 polycistronic operons ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}) ([@B17]), and here we chose at least one gene from each of these operons to perform transcription analysis. It was found that the transcriptional levels of nearly all of the tested genes in *glnR*^--^ strains (i.e., Δ*glnR* and Δ*glnR*/803) were remarkably reduced compared to those in the wild type, especially at 24 h, when their ratio was only ∼1% ([Figure 2](#F2){ref-type="fig"}). When the mutant Δ*glnR* was complemented with an intact *glnR*, the transcriptional levels of most *rif* genes in *glnR*+ were restored to levels comparable with the wild type ([Figure 2](#F2){ref-type="fig"}). In addition, the transcriptional levels of *rif* genes were compared between the wild type U32 and Δ*glnR* when grown in liquid Bennet medium without nitrate supplementation, and it was found that the tested genes in the Δ*glnR* again showed profoundly reduced transcriptional levels at both 24 h and 48 h ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}). These results clearly demonstrate that GlnR is a transcriptional activator for the whole *rif* cluster.

![Transcriptional analyses of the *rif* cluster genes in *A. mediterranei* strains when cultured in liquid Bennet medium containing 80 mM KNO~3~. The relative transcriptional levels of 11 representative genes in the *rif* cluster were measured using qRT-PCR at 24 h **(A)**, 48 h **(B)**, and 72 h **(C)**, respectively. The *rpoB* gene was used as the internal control, and the transcriptional level of the *rifS* gene in U32 at 24 h was used as the reference (i.e., its value was adjusted to 1). Error bars represented the SD from at least three independent biological replicates. U32, the wild type; Δ*glnR*, the *glnR* null mutant; *glnR*+, Δ*glnR* complemented with an intact *glnR*; Δ*glnR*/803, Δ*glnR* integrated with the empty plasmid pDZL803.](fmicb-11-00319-g002){#F2}

GlnR Indirectly Activates the Whole *rif* Cluster Transcription Through Regulating the Expression of the Pathway-Specific Regulator RifZ {#S2.SS2}
----------------------------------------------------------------------------------------------------------------------------------------

Given our findings that GlnR regulates the transcription of all the *rif* genes we tested, and considering the known fact that RifZ is a pathway-specific activator for the whole *rif* cluster, we wondered whether GlnR may indirectly regulate the transcription of all *rif* genes by activating the transcription of the *rifZ* gene. Note that the *rifZ* co-transcribes with the upstream gene *rifJ* and these two genes together form an operon ([@B17]), we then performed EMSA and DNase I footprinting assay to test whether GlnR directly bound to the promoter region of this operon but both obtained negative results ([Figure 3A](#F3){ref-type="fig"} and [Supplementary Figure S4](#SM1){ref-type="supplementary-material"}), which indicated that GlnR cannot directly bind to the promoter of the *rifJ*-*rifZ* operon.

![Analyses of the GlnR binding affinity to the *rifZ* promoter region. **(A)** Analysis of the GlnR binding affinity to the promoter region of the *rifJ-rifZ* operon using EMSA. **(B)** Analysis of the GlnR binding affinity to the *rifZ* promoter region using EMSA. **(C)** Characterization of the GlnR-protected sequences in the *rifZ* promoter via DNase I footprinting assay. Reactions were performed either without (the control reaction, red line) or with (the experimental reaction, blue line) the addition of the GlnR protein, and the electrophoretograms were merged to ease the identification of the GlnR-protected region, which was indicated by a dashed box. The precise DNA sequence was shown at the bottom, and the four predicted typical GlnR-binding sites were highlighted in red.](fmicb-11-00319-g003){#F3}

Noticeably, the length of the intergenic region between *rifJ* and *rifZ* is more than 600 bps. More importantly, from the previously published RNA-seq data set ([@B31]), we found that the transcription of *rifZ* had a more than 10-fold increase relative to the transcription of *rifJ* ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}). Thus, we speculate that in addition to sharing the promoter of the operon, *rifZ* probably also has its own promoter to be operated by transcriptional regulators. To test this hypothesis, we firstly performed EMSA and found GlnR was able to specifically bind to the DNA sequence immediately preceding the gene *rifZ* (i.e., the *rifZ* promoter) ([Figure 3B](#F3){ref-type="fig"}). Subsequently, we employed the DNase I footprinting assay to precisely determine the GlnR-protected DNA sequence in the *rifZ* promoter, and identified a 56-bp region ([Figure 3C](#F3){ref-type="fig"}). In this region, we found two DNA sequences (GTCAC-n6-CTGAC, TGAAC-n6-TTGAC), which well meet the criteria of the GlnR binding sites (i.e., the fourth base should be 'A') ([@B34]). Here both the EMSA and DNase I footprinting results indicate that GlnR can specifically bind to the *rifZ* promoter and thereby directly operate the transcription of the pathway-specific regulator-encoding gene *rifZ*.

Transcription Initiation Site Analysis Reveals *rifZ* Has Its Own Promoter {#S2.SS3}
--------------------------------------------------------------------------

To fully understand this GlnR-mediated transcriptional regulation mechanism, we characterized the transcription initiation site (TIS) of the gene *rifZ* using the primer extension assay. In detail, two specific primers were designed to be complementary to either the *rifZ* coding DNA sequence (CDS) or the *rifZ* promoter region ([Figure 4B](#F4){ref-type="fig"} and [Supplementary Figure S5A](#SM1){ref-type="supplementary-material"}), and both the primer extension results showed that the transcription of *rifZ* began from an adenine (A) site, which was located at the −328th nucleotide (nt) position relative to the translational start site of *rifZ* ([Figure 4](#F4){ref-type="fig"} and [Supplementary Figures S5B,C](#SM1){ref-type="supplementary-material"}). In addition, we also verified the *rifZ* TIS via qRT-PCR using two pairs of primers located upstream and downstream of the TIS, respectively. And results showed that the transcriptional level of the TIS downstream region was much higher than that of the upstream region ([Supplementary Figure S5D](#SM1){ref-type="supplementary-material"}), which further proves this TIS characterized by the primer extension assay.

![Characterization of the *rifZ* promoter. **(A)** Characterization of the *rifZ* TIS via primer extension assay. During the assays two different primers were used, and the primer extension result using the primer rifZ-PE2 was shown here. Locations of both primers as well as the primer extension result using the primer rifZ-PE1 could be found in [Supplementary Figure S5](#SM1){ref-type="supplementary-material"}. After the primer extension reaction, the samples were analyzed by the electrophoresis, whose results were shown in the upper panel. Sequencing results of the promoter region were shown in the bottom panel, and the identified TIS of *rifZ* was marked in red. **(B)** Schematic of the *cis*-elements in the *rifZ* promoter. The TIS of *rifZ* was indicated by a bent arrow and labeled as "P". The GlnR-protected sequences were shown in gray background and the GlnR-binding sites (a site and b site) were shown in red and indicated by arrows. Those two primers (rifZ-PE1 and rifZ-PE2) used for primer extension assays in [Supplementary Figure S5](#SM1){ref-type="supplementary-material"} were also labeled.](fmicb-11-00319-g004){#F4}

Therefore, the primer extension results further demonstrate that the gene *rifZ* undoubtedly has its own promoter. Although the DNase I footprinting-confirmed GlnR binding sequences are positioned downstream of the *rifZ* TIS, we have already established that GlnR positively regulates the transcription of *rifZ* on the basis of the genetic experimental results above ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). Therefore, we speculate that here the GlnR-mediated regulation is unlikely to accord with a typical activation model, wherein an activator binds to the sequence preceding a gene's TIS and recruits the RNA polymerase complex to initiate the transcription.

GlnR Directly Activates the Transcription of the AHBA Synthase-Encoding Gene *rifK* {#S2.SS4}
-----------------------------------------------------------------------------------

Besides *rifZ*, we also tested whether GlnR bound to the promoter regions of other genes in the *rif* cluster. Firstly, our previous work has established that the *rif* cluster consists of 10 polycistronic operons, and these operons in fact shares only six promoter regions as four pairs of them are divergently transcribed (refer to the [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}) ([@B17]). Then, we re-analyzed the transcription profiles of all the *rif* genes in the previously published RNA-seq data set ([@B31]), and found a fascinating phenomenon in their transcription levels: besides the gene *rifZ* mentioned above, there are still six intra-operonic genes had a ≥2-fold transcription increase relative to the transcription of their immediately preceding gene ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}). Thus, it appears that in addition to sharing the promoter of the given operon, these six genes probably also have their own promoter. Finally, coupled with another two experimentally verified intra-operonic promoters of *rifP* ([@B16]) and *rifZ* (just characterized in the [Figure 4](#F4){ref-type="fig"}), there are collectively at least 14 promoters within the *rif* cluster.

Since the two promoters of *rifZ* and *rifJ*-*rifZ* operon had been respectively tested above, here we only analyzed the GlnR binding affinity to the other 12 promoter regions using EMSA. The EMSA results showed that GlnR was able to significantly bind to the *rifK* promoter with a relatively higher binding affinity ([Figure 5A](#F5){ref-type="fig"}). Furthermore, from the [Figure 5A](#F5){ref-type="fig"}, it can be found that GlnR might also bind to another four promoters (*rifS*P, *orf35*P, *rifP*P and *orf6*P), but the binding affinity to them was much reduced relative to the promoters of both *rifK* and *rifZ*.

![Analyses of the GlnR binding affinity to the *rifK* promoter region. **(A)** Analyses of the GlnR binding affinity to 12 promoter regions within the *rif* cluster using EMSA. To prevent the non-specific binding between the GlnR and probes, 2 μg sheared salmon sperm DNA was added into each reaction. Based on the amount of band shift, putative GlnR-targeted promoters were indicated by circles (with strong binding affinity) and dashed circles (with weak binding affinity). **(B)** Characterization of the GlnR-protected sequences in the *rifK* promoter via DNase I footprinting assay. The reactions were performed either without (the control reaction, red line) or with (the experimental reaction, blue line) the addition of the GlnR protein. The precise DNA sequences protected by GlnR were shown at the bottom, and the two predicted typical GlnR-binding sites were highlighted in red. Results of the DNase I footprinting assays of GlnR to other four putative targeted promoters (i.e., the dashed circles in [Figure 5A](#F5){ref-type="fig"}) could be found in [Supplementary Figure S6](#SM1){ref-type="supplementary-material"}.](fmicb-11-00319-g005){#F5}

To verify these (possibly) positive EMSA results in [Figure 5A](#F5){ref-type="fig"} and further understand the binding behavior, we next performed the DNase I footprinting assay to precisely determine the GlnR binding sequences in the five promoter regions, and found that GlnR only specifically protected a region in the *rifK* promoter ([Figure 5B](#F5){ref-type="fig"}) but protected no region in the other four promoters (where the GlnR binding affinity was much reduced during the EMSAs) ([Supplementary Figure S6](#SM1){ref-type="supplementary-material"}). Therefore, these DNase I footprinting results lead us to accurately identify the true positive results of EMSAs, where too much regulatory protein easily generate false positive results.

In the *rifK* promoter, GlnR protected a region from the −280th nt to the −255th nt relative to the *rifK* translational start site ([Figure 6B](#F6){ref-type="fig"}), which did not overlap with the protected region by RifZ, another direct activator for *rifK* transcription ([@B17]). And in the GlnR-protected region, a sequence of "GACAT-n6-GAAAC" was found, which well meets the criteria of the GlnR binding sites ([@B34]). As both GlnR and RifZ activate *rifK* transcription and their binding sequences are not overlapped, we speculate that these two regulators might be cooperative in regulating the transcription of *rifK*. Thereafter, to clarify the relative importance of GlnR and RifZ for the expression of *rifK*, we measured the transcriptional profiles of *rifK* in three strains (U32, Δ*glnR* and Δ*rifZ*) when cultured in liquid Bennet medium with 80 mM nitrate. Interestingly, it was found that the *rifK*'s transcriptional level in Δ*rifZ* was a little higher than in Δ*glnR* at 24 h, while its level in Δ*rifZ* was much lower than in Δ*glnR* at 48 and 72 h ([Supplementary Figure S7](#SM1){ref-type="supplementary-material"}). These results indicate that GlnR may be relatively more important for the *rifK* transcription comparing with RifZ during the early phase, and then the RifZ gradually surpasses the GlnR and plays a dominant role in the *rifK* transcription.

![Characterization of the *rifK* promoter. **(A)** Characterization of the TIS of *rifK* via primer extension assay. **(B)** Schematic of the *cis*-elements in the *rifK* promoter. The TIS of *rifK* was indicated by a bent arrow and labeled as "P". Both the GlnR-protected and RifZ-protected sequences were shown in gray background, and the typical GlnR-binding sites (a site and b site) were shown in red and indicated by arrows. The primer (rifK-PE1) used for the primer extension assay in [Figure 6A](#F6){ref-type="fig"} was also labeled.](fmicb-11-00319-g006){#F6}

Transcription Initiation Site Analysis Reveals *rifK* Has Its Own Promoter {#S2.SS5}
--------------------------------------------------------------------------

To further investigate the molecular mechanism of GlnR-mediated activation of the *rifK* transcription, we performed primer extension assay to identify the TIS of the gene *rifK* using a primer complementary to the −13th nt to the 11th nt of the *rifK* CDS, and found *rifK* transcribed from a guanine (G) site which is located at the −79th nt position relative to the *rifK* translational start site ([Figure 6](#F6){ref-type="fig"}). Noticeably, the -10 box (TAGCCT) of the *rifK* promoter was very similar to the previously characterized −10 box of promoters in *S. coelicolor* and *A. mediterranei* ([@B44]; [@B38]). In addition, as the GlnR-protected region is located upstream of the −35 box in the *rifK* promoter ([Figure 6B](#F6){ref-type="fig"}), we speculate that GlnR might activate the *rifK* transcription through recruiting the RNA polymerase complex using a mode just similar to other typical transcriptional activators.

Discussion {#S3}
==========

The NSE, i.e., the phenomenon that nitrate-stimulated remarkable increase of rifamycin biosynthesis in *A. mediterranei*, was initially demonstrated by our laboratory about 40 years ago ([@B11]). Then it was noticed that the NSE did not occur in the *glnR* null mutant, however, the underlying molecular mechanism is still unknown ([@B45]). In the present study, we uncover the mechanism of GlnR controlling the rifamycin biosynthesis in *A. mediterranei* U32 via multifarious experiments both *in vivo* and *in vitro*.

The phenotypic analyses ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figure S2](#SM1){ref-type="supplementary-material"}) showed that, unlike the previous work in *Streptomyces* ([@B10]), the cellular growth under our cultivation conditions was not impaired by *glnR* deletion at all, which ruled out the impact of the growth factor on gene transcription and on antibiotic production, thus making our conclusions from this study (especially the [Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"} and [Supplementary Figures S2](#SM1){ref-type="supplementary-material"}, [S3](#SM1){ref-type="supplementary-material"}) more reliable. The [Supplementary Figure S2B](#SM1){ref-type="supplementary-material"} showed that Δ*glnR* had a significantly lower yield of rifamycin comparing with the wild type U32 when grown in liquid Bennet medium without nitrate, whereas in our previous work, the rifamycin yield of Δ*glnR* was a little bit higher than that of U32 when grown on Bennet agar plates without nitrate supplementation ([@B45]). Here we speculated this difference might be caused by the cultivation conditions (i.e., liquid medium *versus* solid medium).

During the transcriptional assays, we noticed that the transcriptional levels of *rif* genes in the wild type U32 stayed high till 72 h under nitrate condition ([Figure 2](#F2){ref-type="fig"}) but had dropped dramatically by the time point 48 h without nitrate supplementation ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}). These results were quite consistent with our previous RNA-seq results, where the nitrate supplementation well maintained the high-level transcription of the *rif* cluster (a key character/mechanism of NSE) ([@B31]). And from the [Figure 2](#F2){ref-type="fig"}, we found that the high-level transcription of the *rif* cluster under nitrate condition is severely impaired by the *glnR* deletion (especially at 24 and 48 h), which demonstrates that one reason for GlnR being necessary for NSE is its remarkable up-regulation on the *rif* cluster transcription. Interestingly, the [Supplementary Figure S3](#SM1){ref-type="supplementary-material"} shows that GlnR can also up-regulate the *rif* cluster transcription under no nitrate condition (i.e., NSE cannot occur), indicating that NSE needs other factors besides the GlnR-mediated regulation on the *rif* cluster transcription. Furthermore, the magnitude of the differences in transcriptional levels between the *glnR*^--^ and *glnR*^+^ strains decreased significantly over time ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure S3](#SM1){ref-type="supplementary-material"}), indicating that the *rif* cluster (especially *rifZ* gene) may be controlled by other unknown mechanisms as well, which will be the focus of our future research.

All of the *in vivo* evidence in this study have clearly demonstrated that GlnR is an activator for the transcription of *rifZ* and *rif* cluster. However, the *in vitro* experimental results show that the GlnR binding regions are located downstream of the *rifZ* TIS, which is different from the binding locations of the typical transcriptional activators. In fact, some previous reports have shown that transcriptional regulators can have binding sites downstream of the TIS but still function as activators, e.g., Rns ([@B23]), MetR ([@B5]), PhoP ([@B20]; [@B26]), DnaA ([@B32]), and FleQ ([@B2]), with multiple distinct proposed regulatory mechanisms. Therefore, here we speculate that GlnR probably also activates *rifZ* transcription via an atypical activating model, which is worthy of detailed investigation in the future.

In addition, based on the results of both EMSA and DNase I footprinting assay ([Figures 3](#F3){ref-type="fig"}, [5](#F5){ref-type="fig"}), we noticed that GlnR had lower binding affinity for the *rifK* promoter than for the *rifZ* promoter. For a regulator, an increased number of binding sites in its target sequences usually indicates higher binding affinity. Quite consistent with the different GlnR binding affinities against the two promoters, there are four typical GlnR-binding sites in the *rifZ* promoter, but only two typical GlnR-binding sites in the *rifK* promoter.

Here our study fully illustrates that the well-known global nitrogen regulator GlnR governs the rifamycin biosynthesis via activating the *rif* cluster transcription in both direct and indirect manners in *A. mediterranei* U32 ([Figure 7](#F7){ref-type="fig"}). And combining the results of this study and some previous studies, nowadays we can have a more comprehensive insight that GlnR plays a significant role in NSE by acting as a global regulator to coordinate both primary nitrogen metabolism and secondary metabolism. In detail, when the U32 is cultured in Bennet medium with nitrate, which is a designated nitrogen-limited condition specially for U32 ([@B37]), GlnR activates the transcription of the primary nitrogen metabolism related genes (e.g., *glnA* and *nas* operon) to enhance the glutamine biosynthesis ([@B44]; [@B38]). And it also has been established that the glutamine provides the sole nitrogen atom for rifamycin biosynthesis ([@B13]), therefore GlnR promotes the precursor supply for rifamycin biosynthesis by regulating the primary nitrogen metabolism. In addition to glutamine, the biosynthesis of AHBA is regulated in a very subtle way: on the one hand, GlnR directly activates the transcription of AHBA-synthase-encoding gene *rifK* via binding to its promoter; on the other hand, GlnR indirectly controls the *rifK* transcription *via* activating the expression of the pathway-specific regulator RifZ ([Figure 7](#F7){ref-type="fig"}). As AHBA serves as the starter unit of rifamycin, such a subtle regulation on AHBA synthesis may further facilitate the rifamycin biosynthesis in cells. Besides the gene *rifK*, the GlnR also upregulates the whole *rif* cluster transcription indirectly via activating the *rifZ* expression ([Figure 7](#F7){ref-type="fig"}). And the high-level transcription of the whole *rif* cluster could ensure the accumulation of rifamycin biosynthesis related enzymes in cells. In our opinion, it is quite compelling that the GlnR unexpectedly exerts such sophisticated regulation on rifamycin biosynthesis in *A. mediterranei*, which well interprets our previous findings that the NSE does not occur in the *glnR* null mutant.

![The model of GlnR-mediated activation for the *rif* cluster genes transcription in *A. mediterranei*. It has been established that RifZ functions as the pathway-specific activator for the whole *rif* cluster, therefore GlnR indirectly upregulates the transcription of all the *rif* cluster genes by activating the *rifZ* expression. Besides, the gene *rifK* encodes the AHBA synthase, GlnR therefore directly promotes the biosynthesis of the rifamycin starter unit AHBA by activating the *rifK* transcription. Taken together, GlnR both directly and indirectly activates the *rif* cluster genes transcription to enhance the rifamycin biosynthesis in cells, which further interprets the previous findings that the NSE did not occur in the *glnR* null mutant.](fmicb-11-00319-g007){#F7}

In actinomycetes, GlnR was typically viewed as a global nitrogen metabolism regulator before, governing many nitrogen metabolism related processes ([@B6]; [@B33]; [@B35]; [@B36], [@B38], [@B37]). Recently, several studies have reported that the GlnR homologs in *Streptomyces* regulate the biosynthesis of some antibiotics, e.g., actinorhodin, avermectin and validamycin ([@B27]; [@B10]). Here our study also shows that the GlnR in *A. mediterranei* directly controls the rifamycin biosynthesis. Therefore, taking all these findings together, one may easily conclude that GlnR can function as a global regulator instead of merely a nitrogen metabolism regulator in actinomycetes, coordinating both primary metabolism and secondary metabolism in cells.

Materials and Methods {#S4}
=====================

Bacterial Strains, Media, and Primers {#S4.SS1}
-------------------------------------

All the primers used in this study are listed in [Table 1](#T1){ref-type="table"}. And all the bacterial strains and plasmids used here are listed in [Table 2](#T2){ref-type="table"}. The *glnR* null mutant (Δ*glnR*) was obtained by double crossover recombination ([@B45]; [@B19]). The *glnR* complemented strain (*glnR*+) was constructed by integration of the *glnR* gene with its native promoter into Δ*glnR*, using the integrative plasmid pDZL803 ([@B17]), and the construction procedure was described by [@B19]. *Escherichia coli* DH10B was used for construction of the recombinant plasmids, and was grown in Luria-Bertani (LB) medium ([@B29]). *A. mediterranei* strains were grown aerobically in Bennet medium (10 g/L glycerol, 10 g/L glucose, 2 g/L tryptone, 1 g/L yeast extract, 1 g/L beef extract, pH 7.0) at 30°C ([@B42]; [@B31]). If necessary, antibiotics were added at the following concentrations (μg/ml): ampicillin, 100; and kanamycin, 50.

###### 

Primers used in this study.

  Name                                     Sequences (5′-3′)              
  ---------------------------------------- ------------------------------ -----
  **Primers for qRT-PCR**                                                 
  qRT-rpoB-F                               GAACCGCCCACCAAGGAGAGC          
  qRT-rpoB-R                               CGGTCAGCGTGCCGTTCTCG           
  qRT-rifS-F                               AGCAGCTGGTCGGTGAGGAT           
  qRT-rifS-R                               GGTTCTCCTTCTCCGCCTAC           
  qRT-rifA-F                               TCGAGGACATCCGCGACACT           
  qRT-rifA-R                               TGGTTGCGCAGGTTCCGGTA           
  qRT-rifK-F                               CCGGGCACCGAGGTCATC             
  qRT-rifK-R                               CCGGGTCGAGGTTGTAGG             
  qRT-orf4-F                               TCCGGTGGACCTGCTCAAGA           
  qRT-orf4-R                               AGTAGTCCTGGTCCTCGTGC           
  qRT-orf7-F                               GTGCTGGAACCGTGGATGTA           
  qRT-orf7-R                               CTGCAGGAAGTCGTACTGGT           
  qRT-orf9-F                               ACGCAACGGAATCCGCCATC           
  qRT-orf9-R                               CAGCGTCGAGGTCAGGATCT           
  qRT-orf11-F                              CGATGAACGCGATGGTGTCC           
  qRT-orf11-R                              AAGAAGAGCTACGCCGATCC           
  qRT-orf13-F                              GAAGAACCGTTGCCGCACAC           
  qRT-orf13-R                              ACCGTGAGCACGTCCTCGTA           
  qRT-orf14-F                              ACCGCGAACGACGTCATGGT           
  qRT-orf14-R                              TCGTCCACGTCGGCCTTGTA           
  qRT-orf16-F                              GTTCATGCAGGCGCTGGTCA           
  qRT-orf16-R                              GATGAGCAGCAGGTTGGCGA           
  qRT-rifZ-F                               ATGACCGCCGTCGAGCACAA           
  qRT-rifZ-R                               AGCGCCAGCACGACGTAACT           
  qRT-rifZP1-F                             GAGATTCTCCTTGTGTGCCA           
  qRT-rifZP1-R                             CACAGTAGCTTCGGCGGGAC           
  qRT-rifZP2-F                             CCTGGGGAGGTTGTGGTGGT           
  qRT-rifZP2-R                             AATGTAATGCGCGCCGTGTC           
  **Primers for preparation of probes**    **Probe size (bps)**           
  rifSP-F                                  ACTCGAACGGCACCTCATCGTC         400
  rifSP-R                                  CGCCGGTGGGAGCCATTACCAA         
  orf35P-F                                 AGACCTGGAGGCGTTGATGCT          335
  orf35P-R                                 CTCATCGCGGCCTCCACCTGT          
  rifFP-F                                  CCCGTGCGGCGTCCACTGT            329
  rifFP-R                                  CCACGTCGAACACGTTCACACCT        
  rifKP2-F                                 CGGACGTCGGTGTCGGCC             433
  rifKP-R                                  AGGGAATTCCGGTGCCTTTCG          
  rifOP-F                                  ACGCGCTGGAAGGAAGCACCC          340
  rifOP-R                                  AGAGTGCCCATGGCGCCGAAC          
  rifPP2-F                                 CGGGGTGGCTCGCCGGATC            478
  rifPP2-R                                 GACGAGGGCGTAGGCGTTGAT          
  rifQP-F                                  CGCCGTGCTCAACTCGCGGTTC         344
  rifQP-R                                  CCGTTTGCCCATCGTGGCCCTC         
  orf5P-F                                  CGAGCTGGTTCGGGTTCATCATC        364
  orf5P-R                                  TCATGGGGTCCTTCCTTTCGT          
  orf6P-F                                  CGACGCCGTGGTCATCACCT           315
  orf6P-R                                  ACCATGTCGTATCGATCCCTGC         
  orf11P-F                                 CCAGCAGCGCCGAATAGCCCTC         345
  orf11P-R                                 CTCCCAGTGGCCATAACGGCAAA        
  orf18P-F                                 GGAGATGAAGAAGCTGCTG            223
  orf18P-R                                 CCGCCATGGACATGACCGC            
  orf14P-F                                 CGGCGACCACTTCCGGTGAGAAC        341
  orf14P-R                                 CGGCTTCGTCACCAGTACCCCT         
  rifJP-F                                  CGCCGACCAGCTCGCCCTC            391
  rifJP-R                                  GCGTTTTCGGTCACTTTGGTCGT        
  rifZP-F                                  GTCCCGCCGAAGCTACTGTG           362
  rifZP-R                                  CCGCTGCATCAAATCGTCCC           
  *Hin*cII-F                               GTAAAACGACGGCCAGTGCG           
  *Hin*cII-R                               FAM-AACAGCTATGACCATGATTACGG    
  **Primers for primer extension assay**                                  
  rifK-PE1                                 FAM-CGCGCGTTCATGGTTCTCCGAATC   
  rifZ-PE1                                 FAM-GAGGAAACCAGCGGTGTCACAGG    
  rifZ-PE2                                 FAM-TCACACGACAGCACCGAATG       

###### 

Strains and plasmids used in this study.

  Strains or plasmids            Relevant characteristics                                                                                                          Sources
  ------------------------------ --------------------------------------------------------------------------------------------------------------------------------- ---------------
  **Strains**                                                                                                                                                      
  *E. coli* DH10B                F^--^ *endA1 recA1 galE15 galK16 nupG rpsL* Δ*lacX74* Φ80*lacZ*ΔM15 *araD139* Δ(ara,leu)7697 *mcrA* Δ(*mrr-hsdRMS-mcrBC*) λ^--^   Lab stock
  *E. coli* BL21(DE3)            F^--^ *ompT gal dcm lon hsdSB*(rB- mB-) λ(DE3)                                                                                    NEB
  *A. mediterranei* U32          Wild type; an industrial producer of rifamycin SV                                                                                 Lab stock
  *A. mediterranei*Δ*glnR*       *glnR* null mutant                                                                                                                [@B19]
  *A. mediterranei glnR* +       Complementary strain; *glnR* null mutant complemented using an integrating vector with an intact *glnR*                           [@B19]
  *A. mediterranei*Δ*glnR*/803   *glnR* null mutant with empty vector                                                                                              [@B19]
  *A. mediterranei*Δ*rifZ*       *rifZ* null mutant                                                                                                                [@B17]
  **Plasmids**                                                                                                                                                     
  pEXAMR                         GlnR expression plasmid with the *glnR* (*AMED_9008*) gene cloned into the *Eco*RI and *Hin*dIII sites of pET28a (+)              [@B38]
  pDZL803                        An integrative plasmid used in *A. mediterranei*, resistant to apramycin and hygromycin                                           [@B17]
  pUC18H                         A plasmid derived from pUC18 with most restriction sites removed but the *Hin*cII site                                            Tolo Biotech.
  pUC18H-rifSP                   The promoter region of *rifS*-*rifT* operon cloned into the *Hin*cII site of pUC18H                                               This work
  pUC18H-orf35P                  The promoter region of *orf35*-*rifQ* operon cloned into the *Hin*cII site of pUC18H                                              This work
  pUC18H-rifKP                   The promoter region of the gene *rifK* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-rifFP                   The promoter region of the gene *rifF* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-rifOP                   The promoter region of the gene *rifO* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-rifQP                   The promoter region of the gene *rifQ* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-orf5P                   The promoter region of the gene *orf5* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-orf6P                   The promoter region shared by *orf6*-*orf3* operon and *orf7*-*orf8* operon cloned into the *Hin*cII site of pUC18H               This work
  pUC18H-orf11P                  The promoter region shared by *orf10*-*orf9* operon and *orf11*-*orf18* operon cloned into the *Hin*cII site of pUC18H            This work
  pUC18H-orf18P                  The promoter region of the gene *orf18* cloned into the *Hin*cII site of pUC18H                                                   This work
  pUC18H-orf14P                  The promoter region shared by *orf13*-*orf19* operon and *orf14*-*orf15B* operon cloned into the *Hin*cII site of pUC18H          This work
  pUC18H-rifJP                   The promoter region shared by *orf16* and *rifJ*-*rifZ* operon cloned into the *Hin*cII site of pUC18H                            This work
  pUC18H-rifPP                   The promoter region of the gene *rifP* cloned into the *Hin*cII site of pUC18H                                                    This work
  pUC18H-rifZP                   The promoter region of the gene *rifZ* cloned into the *Hin*cII site of pUC18H                                                    This work

Measurement of the Growth Curve and Rifamycin Yield {#S4.SS2}
---------------------------------------------------

After streak cultivation on Bennet plates for 4--5 days, *A. mediterranei* strains were transferred into 50 ml liquid Bennet medium containing ceramic beads (diameter: 2.5 mm) to avoid mycelia aggregation. After incubation in a shaker at 220 rpm for about 36 h, they were inoculated into 200 ml fresh liquid Bennet medium containing ceramic beads and 0/80 mM KNO~3~ with the final OD~600~ = 0.2. The growth curves of different strains were determined by measuring the OD~600~ values with NanoDrop 2000C (Thermo Fisher Scientific) every 12 h.

After the strains being inoculated into 200 ml liquid Bennet medium with 0 or 80 mM KNO~3~ for 24 h, 1 ml bacterial suspensions were taken from the fermentation broth at 12 h intervals. For determining the rifamycin yield, the samples were centrifuged and the supernatant was collected. Then the rifamycin yield was measured using the spectrophotometric method as previously described ([@B24]). Briefly, 20 μl supernatant was diluted in 180 μl acetate buffer containing 0.1% NaNO~2~ or 0.1% vitamin C, respectively. Then, the optical density was read at the wavelength of 447 nm, with the NaNO~2~ group taken as a blank control. Finally, the yield of rifamycin was calculated based on a standard curve prepared by using pure rifamycin SV as standards.

RNA Extraction and Quantitative Real-Time PCR (qRT-PCR) {#S4.SS3}
-------------------------------------------------------

When *A. mediterranei* strains were grown in liquid Bennet medium with 0/80 mM KNO~3~ for 24, 48, and 72 h, 5--10 ml bacterial suspensions were collected and the mycelia were harvested at 4°C by centrifugation at 12,000 rpm for 5 min. Total RNA was then extracted from the mycelia using TRIzol reagent (Thermo Fisher Scientific) and SV Total RNA Isolation System (Promega), following the manufacturers' instruction. Reverse transcription was performed with random primers using 1 μg total RNA as the template in a volume of 20 μl by the PrimeScript 1st Strand cDNA synthesis kit (TaKaRa), and the qRT-PCR was carried out with SYBR Premix Ex Taq II (Tli RNaseH Plus) (TaKaRa). At least three independent biological samples were tested in this experiment, and the relative transcriptional level of the tested genes was presented as means ± standard deviations (SD), using the *rpoB* gene as the internal control.

Preparation of FAM-Labeled Probes {#S4.SS4}
---------------------------------

Promoter regions in *rif* cluster were PCR amplified with Phanta Max super-fidelity DNA polymerase (Vazyme), employing primers listed in [Table 1](#T1){ref-type="table"}. Then these PCR amplicons were separately cloned into the *Hin*cII site of pUC18H (Tolo Biotech.). After verification through DNA sequencing, these recombinant plasmids were used as the PCR templates to prepare FAM-labeled probes using primers of *Hin*cII-F and *Hin*cII-R (6-carboxyfluorescein \[FAM\] labeled). Finally, the FAM-labeled probes were purified by the Wizard SV gel and the PCR Clean-Up system (Promega), and quantified with NanoDrop 2000C (Thermo Fisher Scientific).

Electrophoretic Mobility Shift Assay (EMSA) and DNase I Footprinting Assay {#S4.SS5}
--------------------------------------------------------------------------

The heterogenous expression and purification of the His-tagged GlnR of *A. mediterranei* U32 were performed as previously described ([@B38]). EMSA was carried out using the purified His-tagged GlnR and FAM-labeled probes, following the same procedures as described in our previous work ([@B17]). DNase I footprinting assay was performed by Tolo Biotech. according to the method described by [@B36]. In brief, each FAM-labeled probe of about 300 ng was incubated with different amounts of His-tagged GlnR for 30 min at 25°C. After DNase I digestion, the stop solution was added to stop the reaction. The promoter region was sequenced using specific primer with FAM labeled at the 5′-ends, following the procedures described before ([@B36]). The samples together with the sequencing products were then purified and loaded into an ABI 3130 sequencer for electrophoresis analysis. The electropherograms were analyzed with PeakScanner v1.0 software (Applied Biosystems) to characterize the precise DNA sequences protected by GlnR.

Primer Extension Assay {#S4.SS6}
----------------------

Primer extension assay was carried out by Tolo Biotech ([@B16]). To prepare total RNA for primer extension assay, *A. mediterranei* U32 was inoculated into liquid Bennet medium with 80 mM KNO~3~ and incubated in a shaker at 30°C for about 36 h. Then, the mycelia were harvested by centrifugation, followed by extraction of the total RNA using a protocol the same as described above. For each assay, about 60 μg total RNA was used to characterize the TIS, employing FAM-labeled primers listed in [Table 1](#T1){ref-type="table"}. Sequencing analysis of the promoter region with the FAM-labeled primer was the same as that described before ([@B16]). The subsequent electrophoresis and analysis were the same as the procedures in the DNase I footprinting assay described above.

Data Availability Statement {#S5}
===========================
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AHBA

:   3-amino-5-hydroxybenzoic acid

CDS

:   coding DNA sequences

EMSA

:   electrophoretic mobility shift assay

NSE

:   nitrate-stimulating effect

qRT-PCR

:   quantitative real-time PCR

TIS

:   transcription initiation site.
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